TEIJIN PHARMA, SATO PHARMACEUTICAL JOINTLY INTRODUCE ANTIPSORIATIC AGENT BONALFA

A A

Teijin Pharma and Sato Pharmaceutical jointly announced on June 26 that they will begin marketing Bonalfa High Lotion 20 mu-g/g (tacalcitol), an ethical agent for treating psoriasis vulgaris, on June 27.

JCN Network (http://www.japancorp.net/Article.Asp?Art_ID=12772)